Enhancer Detail

Comprehensive information about experimentally validated enhancers

About Enhancer
Enhancer ID: E_05249
Species: Homo sapiens
Position : chr8:129546728-129712179
Year: 2019
Title: Acute depletion of CTCF directly affects MYC regulation through loss of enhancer-promoter looping.
Genome Build: hg19
Enhancer Type: Enhancer
Condition: Disease
Disease Name: B-cell acute lymphoblastic leukemia
PMID:  31127282
MONDO: MONDO:0004947
Tissue: blood
Tissue Ontology ID: UBERON:0000178
Cell Source: SEM B-ALL cells
Cell Type: B-lymphoblast/precursor B cell
Experiment Type: Acute architectural-factor depletion; enhancer-promoter interaction analysis; target-gene response
High Throughput Method: RNA-seq; Hi-C/chromosome-conformation profiling; CTCF chromatin profiling
Low Throughput Method: Auxin-inducible CTCF degradation; targeted chromatin-conformation assay; RT-qPCR; Western blot
About Target Gene
Target gene : MYC
About TF
TF name : CTCF
About Regulatory State
Regulatory State : Active
Upstream Pathway Annotation of TF
GeneName Pathway Name Source Gene Number
CTCF Activation of anterior HOX genes in hindbrain development during early embryogenesis reactome 120
CTCF TGF_beta_Receptor netpath 220
Enhancer Associated Network
Overlapping Enhancers (hg19) 3 found
Enhancer ID Position Tissue Cell Disease
E_00939 chr8:129543949-129554294 uterus malignant cell endometrial carcinoma
E_00976 chr8:129543949-129554294 endometrium malignant cell endometrial carcinoma
E_00977 chr8:129543949-129554294 endometrium epithelial cell endometrial carcinoma
Expression of Target Genes for the Enhancer